FDA warns consumers regarding copycat Lumify eyedrops

FDA warns consumers regarding copycat Lumify eyedrops

While no adverse events have been reported for any of the copycat products, the agency has received complaints of quality concerns, eye irritation, pain and infection.
The health benefits of Epsom salt Reading FDA warns consumers regarding copycat Lumify eyedrops 1 minute Next Turning 65 - Part 1 - Getting My Medicare Card

Consumers are being warned by the Food and Drug Administration (FDA) not to use unapproved eye drops that closely resemble Bausch & Lomb's Lumify product. 

The over-the-counter eye drop, Lumify, is used to alleviate redness in the eye caused by minor irritation. The copycat products in question are South Moon, Rebright and FivFivGo and are easily mistaken for Lumify. The FDA said they are unable to determine the origin of the copycat products.

Tests conducted on South Moon revealed contamination by bacteria that could cause an antibiotic-resistant infection. Rebright tested negative for contamination but the FDA still advises consumers not to use the product. FivFivGo was not tested because the FDA was unable to secure samples.

While no adverse events have been reported for any of the copycat products, the agency has received complaints of quality concerns, eye irritation, pain and infection.

USA Only, Spend $50, get free shipping

Free shipping is currently available for orders within the United States only.